Internal Medicine, Endocrinology, Diabetes, & Metabolism · Boca Raton, FL
NPI
1194808063
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
7301 W Palmetto Park Rd, Suite 108b
Boca Raton, FL, 33433
Phone (561) 391-4441
Groups this clinician bills Medicare through
Medicare paid, 2024
$550K
19,296 services
Medicare patients, 2024
1,506
Average age 79
Drug cost, 2024
$3.1M
10,034 prescriptions
Company payments, 2025
$1,002
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David I Levenson was code 82962 (clinical chemistry), 2,428 times for 1,202 patients. In total David I Levenson billed 19,296 services in 85 codes, and Medicare paid $550K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82962 Clinical Chemistry | Office | 2,428 | 1,202 | $3.21 | $7,794 |
| 99214 Office E&M - Established | Office | 2,143 | 1,189 | $93.28 | $200K |
| 36415 Venipuncture Blood Collection | Office | 1,695 | 881 | $8.65 | $15K |
| 83036 Blood Count | Office | 1,523 | 885 | $9.52 | $14K |
| 80048 Clinical Chemistry | Office | 1,028 | 681 | $8.29 | $8,522 |
| 84443 Clinical Chemistry | Office | 994 | 687 | $16.46 | $16K |
| 84439 Clinical Chemistry | Office | 991 | 685 | $8.84 | $8,760 |
| 83721 Clinical Chemistry | Office | 867 | 660 | $10.29 | $8,921 |
| 80061 Clinical Chemistry | Office | 867 | 660 | $13.12 | $11K |
| 99215 Office E&M - Established | Office | 684 | 515 | $132.40 | $91K |
| 95251 Test - Miscellaneous | Office | 547 | 270 | $26.71 | $15K |
| 80076 Clinical Chemistry | Office | 477 | 385 | $8.01 | $3,821 |
| 99212 Office E&M - Established | Office | 446 | 343 | $28.76 | $13K |
| 99213 Office E&M - Established | Office | 360 | 269 | $54.86 | $20K |
| 82570 Clinical Chemistry | Office | 284 | 264 | $5.08 | $1,443 |
By year: 2022 $610K for 24,674 services; 2023 $534K for 20,869 services; 2024 $550K for 19,296 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 2,428 | 1,202 | $3.21 | $7,794 |
| 36415 Venipuncture Blood Collection | 1,695 | 881 | $8.65 | $15K |
| 83036 Blood Count | 1,523 | 885 | $9.52 | $14K |
| 80048 Clinical Chemistry | 1,028 | 681 | $8.29 | $8,522 |
| 84443 Clinical Chemistry | 994 | 687 | $16.46 | $16K |
| 84439 Clinical Chemistry | 991 | 685 | $8.84 | $8,760 |
| 83721 Clinical Chemistry | 867 | 660 | $10.29 | $8,921 |
| 80061 Clinical Chemistry | 867 | 660 | $13.12 | $11K |
| 80076 Clinical Chemistry | 477 | 385 | $8.01 | $3,821 |
| 82570 Clinical Chemistry | 284 | 264 | $5.08 | $1,443 |
Medicare prescription drug claims, 2024
In 2024, the drug David I Levenson prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,627 prescriptions and refills. In total David I Levenson wrote 10,034 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,627 | 4,658 | 434 | $20K |
| Rosuvastatin Calcium Generic | 624 | 1,816 | 203 | $11K |
| Synthroid Levothyroxine Sodium | 563 | 1,613 | 137 | $42K |
| Metformin Hcl Er Metformin Hcl | 528 | 1,542 | 166 | $8,084 |
| Atorvastatin Calcium Generic | 512 | 1,491 | 164 | $5,977 |
| Ozempic Semaglutide | 352 | 565 | 82 | $496K |
| Metformin Hcl Generic | 289 | 863 | 90 | $2,805 |
| Nateglinide Generic | 272 | 719 | 96 | $13K |
| Mounjaro Tirzepatide | 268 | 354 | 56 | $366K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 258 | 679 | 92 | $30K |
| Ezetimibe Generic | 208 | 619 | 72 | $7,330 |
| Jardiance Empagliflozin | 200 | 521 | 63 | $283K |
| Losartan Potassium Generic | 198 | 579 | 58 | $2,378 |
| Alendronate Sodium Generic | 179 | 497 | 62 | $2,104 |
| Trulicity Dulaglutide | 164 | 220 | 26 | $207K |
Brand drugs: 4,207 claims; generic drugs: 5,327 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David I Levenson $1,002 ($1,002 in general payments such as food, travel and fees) from 17 companies. The largest payer was Medicure Pharma Inc. with $195.
| Company | Payments | Amount |
|---|---|---|
| Medicure Pharma Inc. | 1 | $195 |
| Genzyme Corporation SNY | 1 | $125 |
| Amgen Inc. AMGN | 6 | $118 |
| Corcept Therapeutics CORT | 4 | $95.64 |
| Dexcom, Inc. DXCM | 4 | $76.26 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $67.14 |
| Recordati_rare_diseases_inc. | 3 | $60.98 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $50.19 |
| Mannkind Corporation MNKD | 2 | $37.38 |
| Sequel Med Tech, LLC | 1 | $30.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.